What does a normal Pap smear showing inflammatory cells indicate, and what evaluation and treatment should be pursued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Pap Smear with Inflammation: Evaluation and Management

A normal Pap smear showing inflammatory cells typically requires no immediate intervention, but if severe inflammation with reactive cellular changes is present, repeat the Pap smear in 3 months after treating any identifiable underlying infection. 1

Understanding the Finding

A Pap smear reported as "normal" or "negative for intraepithelial lesion or malignancy" (NILM) with inflammatory cells is a common finding that does not indicate cervical cancer or precancerous changes. The inflammatory cells represent a benign reactive process. However, the clinical significance depends on the degree of inflammation and associated findings.

Key Distinction: Degree of Inflammation Matters

The management pathway differs based on severity:

Mild to Moderate Inflammation

  • No specific follow-up required beyond routine screening intervals 1
  • Continue regular Pap smears according to age-appropriate guidelines (typically every 3 years for ages 21-65, or every 5 years with co-testing for ages 30-65)
  • The Pap smear is not a screening test for STDs 2

Severe Inflammation with Reactive Cellular Changes

  • Repeat Pap smear in 3 months 1
  • If possible, identify and treat underlying infection before the repeat smear
  • This approach prevents missing dysplastic changes that may be obscured by severe inflammation

Evaluation for Underlying Infections

While inflammation on Pap smear does not reliably predict specific infections (research shows only 60% correlation with positive cultures in asymptomatic women 3), consider evaluation if:

  • Clinical symptoms are present: vaginal discharge, cervical mucopurulent discharge, contact bleeding, or pelvic pain
  • Cervical examination is abnormal: visible cervicitis, mucopus, or cervical erosion
  • Patient is in a high-risk setting: STD clinic population or multiple risk factors

Testing to consider when clinically indicated:

  • Cervical cultures or nucleic acid amplification tests for Chlamydia trachomatis and Neisseria gonorrhoeae
  • Wet mount or testing for Trichomonas vaginalis
  • Evaluation for bacterial vaginosis
  • Consider herpes simplex virus testing if ulcerations present

Important Caveats and Pitfalls

Do not empirically treat inflammation without identified pathogen. Research demonstrates that empiric metronidazole treatment for inflammatory Pap smears shows no benefit in resolving cytologic changes 4. Treatment should be directed at specific identified organisms.

Do not defer the Pap smear unnecessarily. While older guidelines suggested deferring Pap smears in the presence of obvious severe cervicitis until after treatment 1, current practice recognizes that most Pap smears remain satisfactory for evaluation even with infection present 2. The presence of mucopurulent discharge should not delay the Pap test—it can be performed after careful removal of discharge with a saline-soaked swab 2.

Be aware of persistent inflammation. If inflammation persists on repeat Pap smears despite treatment of identified infections, research suggests 16-53% of these women may harbor cervical intraepithelial neoplasia (CIN) 5, 6. Consider colposcopy for women with persistent inflammatory smears after appropriate treatment, particularly if:

  • Two consecutive Pap smears show inflammation
  • Clinical risk factors are present (early age at first intercourse, contact bleeding, cervical erosion)
  • The patient is in a high-risk population

When Colposcopy Is NOT Indicated

Colposcopy is not recommended for:

  • Initial finding of mild-moderate inflammation on an otherwise normal Pap smear
  • Asymptomatic women with normal cervical examination
  • Inflammation that resolves on repeat testing

Patient Communication

Reassure patients that:

  • Inflammatory cells on a normal Pap smear do not indicate cancer or precancerous changes
  • This is a common, benign finding
  • Routine screening intervals can continue unless severe inflammation is noted
  • Any identified infections will be treated appropriately

The key is distinguishing between mild inflammation (which requires no action beyond routine follow-up) and severe inflammation with reactive changes (which warrants repeat testing in 3 months). This evidence-based approach balances appropriate surveillance against unnecessary interventions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.